S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
Clinical trial NCT00085709 · COMPLETED
Trial details
- NCT number
- NCT00085709
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2010-03-01
- Enrollment
- 637
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.